Irbesartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63187-981

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 63187-981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Image 01)

A line graph comparing the percentage of patients with systolic blood pressure (SBP) less than 140 mmHg against baseline SBP values from 140 to 220 mmHg. The graph includes data from multiple studies labeled as Irbesartan and HCTZ Study V, Irbesartan Study V, HCTZ Study VI, Irbesartan and HCTZ Study VI, and Irbesartan Study VI, distinguished by different colored and patterned lines.*

FDA Label Image

Figure 1b (Image 02)

A line graph showing the percentage of patients with systolic blood pressure (SBP) less than 130 mmHg plotted against baseline SBP values ranging from 140 to 220 mmHg. The graph includes multiple lines representing different studies and treatment groups involving Irbesartan and Hydrochlorothiazide and their respective SBP responses.*

FDA Label Image

Image02a (Image 03)

A line graph showing the percent change in diastolic blood pressure (DBP) from baseline across different baseline DBP values (90 to 130 mmHg). The graph includes four lines representing results from Irbesartan and Hydrochlorothiazide combination therapy and individual studies labeled Study V and Study VI for each treatment.*

FDA Label Image

Image02b (Image 04)

A line graph comparing the percentage of diastolic blood pressure (DBP) less than 90 mmHg against baseline DBP values (mmHg) for different studies involving Irbesartan and Hydrochlorothiazide (HCTZ), Irbesartan alone, and HCTZ alone. The graph includes data from Study V and Study VI with distinct lines for each treatment group.*

FDA Label Image

Irbesartan Chemical Structure (Image 05)

Chemical structure diagram of Irbesartan, one of the active ingredients in Irbesartan and Hydrochlorothiazide tablets. The image shows the molecular framework comprising rings and side chains characteristic of Irbesartan.*

FDA Label Image

Hctz Chemical Structure (Image 06)

Chemical structure of the active ingredient Irbesartan and Hydrochlorothiazide, showing molecular bonds and functional groups.*

FDA Label Image

Figure03 (Image 07)

A scatter plot with a fitted curve showing the relationship between Irbesartan dose (mg/day) on the x-axis and a measurement in mmHg on the y-axis. The data points demonstrate an increasing trend in mmHg with higher Irbesartan doses, leveling off as doses approach 900 mg/day.*

FDA Label Image

Figure04 (Image 08)

A dose-response curve chart depicting the relationship between Irbesartan dose (mg/day) on the x-axis and blood pressure change (mmHg) on the y-axis. Scatter points with a fitted curve indicate increasing blood pressure effect up to around 450 mg/day dose, leveling off thereafter.*

FDA Label Image

63187-981-30 (Image 09)

Label for Irbesartan 150 mg and Hydrochlorothiazide 12.5 mg film-coated tablets, package of 30, relabeled by Proficient Rx LP. The label includes the NDC 63187-981-30, manufacturer TEVA Pharmaceutical Industries Ltd. in Jerusalem, Israel, and storage instructions 20°-25°C (68°-77°F). The tablets are described as light pink to pink, capsule-shaped, debossed with 'TEVA' and '7238'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.